10.1016/j.physbeh.2010.12.006 61 DossatA
By reducing the oxidative burden on the brainstem and prefrontal cortex, this combination therapy has shown remarkable, life-changing success in improving orthostatic tolerance, reducing tachycardia, and restoring cognitive stamina in severely affected patients
B12 on 3 consecutive days (dose reported as 1 mg/ml, form not reported) alongside valaciclovir (an antiviral drug) for 5 days and diclofenac (a non-steroidal anti-inflammatory drug) versus valaciclovir and diclofenac alone
See the vial planning section above for detailed calculations by titration phase
Any papers resulting from these two trials do not appear to be indexed in major global databases like PubMed, and its not clear if they were ever published in peer-reviewed journals
Compounding pharmacies do produce rapid-dissolve sublingual tablets and they are sold with a prescription, but the clinical evidence for meaningful IGF-1 elevation through this route is not comparable to injectable therapy
